【Asuka Pharmaceutical】Share Buyback for Employee Shareholding Association | November 2, 2026

Summary of the Disposal

Asuka Pharmaceutical plans to allocate 22,198 shares of treasury stock as transfer-restricted stock to the employee shareholding association. The disposal price is ¥2,259 per share, with a total of approximately ¥50.1 million, scheduled for November 2, 2026. The system aims to improve employee engagement and enhance corporate value over the medium to long term, applicable to up to 777 target employees.

Purpose and Background of the System

This system was introduced to support employees' wealth formation and to promote value sharing between employees and shareholders, aiming to enhance corporate value. The dilution scale of the disposed shares is approximately 0.08% of all issued shares, considered to have a limited market impact. The disposal will be carried out during the transfer restriction period, with conditions set for transfer restriction release based on continued employment, resignation, overseas transfer, etc., of employees.